Advertisement

Transjugular Intrahepatic Portosystemic Stent-Shunt

Technical Considerations and Clinical Utility in the Management of Variceal Hemorrhage
  • Dhiraj Tripathi
  • Peter C. Hayes
  • Doris N. Redhead
  • Rajiv Jalan
Part of the Clinical Gastroenterology book series (CG)

Abstract

Transjugular intrahepatic portosystemic stent-shunt (TJPSS) is a nonsurgical means of diverting blood from the portal circulation through the hepatic parenchyma to the systemic circulation, thereby creating a portosystemic shunt. Hie internal jugular vein is first entered percutaneously, and a catheter is passed through the superior vena cava, right atrium, inferior vena cava, and, in most cases, the right hepatic vein under fluoroscopic guidance. A needle is inserted through the catheter to puncture the hepatic parenchyma, creating a tract to link the hepatic vein and usually the right portal vein. This tract is kept patent using an expandable metal stent. Where successful, this results in immediate decompression of the portal circulation and elimination of portal hypertension.

Keywords

Transjugular Intrahepatic Portosystemic Shunt Variceal Bleeding Portal Pressure Gastric Varix Primary Patency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a metaanalysis. Hepatology 1999;30(3):612–622.PubMedCrossRefGoogle Scholar
  2. 2.
    Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969;92(5):1112–1114.PubMedGoogle Scholar
  3. 3.
    Rosch J, Hanafee W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portacaval shunt. An experimental work. Am J Surg 1971;121(5):588–592.PubMedCrossRefGoogle Scholar
  4. 4.
    Koch G, Rigler B, Tentzeris M, Schuy S, Sakulin M, Schmidt-Kloiber H. The intrahepatic portocaval shunt. Langenbecks Arch Chir 1973;333(3):237–244.PubMedCrossRefGoogle Scholar
  5. 5.
    Reich M, Olumide F, Jorgensen E, Eiseman B. Experimental cryoprobe production of intrahepatic portocaval shunt. J Surg Res 1977;23(1):14–18.PubMedCrossRefGoogle Scholar
  6. 6.
    Burgener FA, Gutierrez OH. Experimental intrahepatic portocaval shunts created in portal hypertension by balloon angioplasty catheters. Invest Radiol 1988;23(l):24–29.PubMedGoogle Scholar
  7. 7.
    Colapinto RF, Stronell RD, Birch SJ, et al. Creation of an intrahepatic portosystemic shunt with a Gruntzig balloon catheter. Can Med Assoc J 1982;126(3):267–268.PubMedGoogle Scholar
  8. 8.
    Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol 1985;145(4):821–825.PubMedGoogle Scholar
  9. 9.
    Palmaz JC, Garcia F, Sibbitt RR, et al. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR Am J Roentgenol 1986;147(6):1251–1254.PubMedGoogle Scholar
  10. 10.
    Rockey DC. Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy. Gastroenterology 2000;118(6):1261–1265.PubMedCrossRefGoogle Scholar
  11. 11.
    Kowalaski B, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 1953:32:1025–1033.Google Scholar
  12. 12.
    Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958:32:358–367.CrossRefGoogle Scholar
  13. 13.
    Lowke HF Reduction of hypertension after liver disease. Arch Intern Med 1962;110:45–52.Google Scholar
  14. 14.
    Mashford ML, Mahow WA, Chalmers TC. Studies of the cariovascular system in the hypotension of liver failure. N Engl J Med 1962;267:1071–1074.PubMedCrossRefGoogle Scholar
  15. 15.
    Plevris JN, Hauer JL, Hayes PC, Bouchier IA. Blood pressure and liver cirrhosis. J Hum Hypertens 1990;4(6):725–726.PubMedGoogle Scholar
  16. 16.
    D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analy tic review. Hepatology 1995;22(l):332–354.PubMedCrossRefGoogle Scholar
  17. 17.
    Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002;51(2):270–274.PubMedCrossRefGoogle Scholar
  18. 18.
    Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999;29(3):632–639.PubMedCrossRefGoogle Scholar
  19. 19.
    Kleber G, Steudel N, Behrmann C, et al. Hepatic arterial flow volume and reserve in patients with cirrhosis: use of intra-arterial Doppler and adenosine infusion. Gastroenterology 1999;116:906–914.PubMedCrossRefGoogle Scholar
  20. 20.
    Zipprich A, Steudel N, Behrmann C, et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 2003;37:385–392.PubMedCrossRefGoogle Scholar
  21. 21.
    Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens thehyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994;19:129–132.PubMedGoogle Scholar
  22. 22.
    Tripathi D, Helmy A, Macbeth K, et al. Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hcpatol 2004;19:9–18.CrossRefGoogle Scholar
  23. 23.
    Sanyal AJ, Reddy KR. Vegetative in fection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;115(1):110–115.PubMedCrossRefGoogle Scholar
  24. 24.
    Jalan R, Redhead DN, Allan PL, Hayes PC. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TTPSS). Eur J Gastroenterol Hepatol 1996;8(4):381–385.PubMedCrossRefGoogle Scholar
  25. 25.
    Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 2002;37(3):249–252.PubMedCrossRefGoogle Scholar
  26. 26.
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995;23(2):123–128.PubMedCrossRefGoogle Scholar
  27. 27.
    Jalan R, Stanley AJ, Redhead DN, Hayes PC. Shunt insufficiency after transjugular intrahepatic portosystemic stent-shunt: the whens, whys, hows and what should we do about it? [editorial]. Clin Radiol 1997;52(5):329–331.PubMedCrossRefGoogle Scholar
  28. 28.
    Jalan R, Dabos K, Redhead DN, Lee A, Hayes PC. Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1997;27:928–933.PubMedCrossRefGoogle Scholar
  29. 29.
    Sze DY, Vestring T, Liddell RP, et al. Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents. Cardiovasc Intervent Radiol 1999;22(4):298–304.PubMedCrossRefGoogle Scholar
  30. 30.
    Jalan R, Harrison DJ, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol 1996;24(2):169–176.PubMedCrossRefGoogle Scholar
  31. 31.
    Sauer P, Theilmann L, Herrmann S, et al. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology 1996;24(6):1433–1436.PubMedGoogle Scholar
  32. 32.
    Siegerstetter V, Huber M, Ochs A, Blum HE, Rossle M. Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. Hepatology 1999;29(1):33–38.PubMedCrossRefGoogle Scholar
  33. 33.
    Ferguson JM, Jalan R, Redhead DN, Hayes PC, Allan PL. The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS). Br J Radiol 1995;68(810):587–589.PubMedGoogle Scholar
  34. 34.
    Shah SH, Lui IIP, Helmy A, Redhead DN, Penny K, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus. Eur J Gastroenterol Hepatol 2001;13(3):257–261.PubMedCrossRefGoogle Scholar
  35. 35.
    Balata S, Lui HF, Helmy A, Tripathi D, Redhead DN, Hayes PC. Role of technical variables in early shunt insufficiency following TIPSS for the treatment of portal hypertension. Gut 2002;50:427.Google Scholar
  36. 36.
    Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99(5):1401–1407.PubMedGoogle Scholar
  37. 37.
    Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 2003;18(3):253–262.PubMedCrossRefGoogle Scholar
  38. 38.
    Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000;46(Suppl 3–4):III1–III15.PubMedGoogle Scholar
  39. 39.
    Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 1996;39(3):479–485.PubMedCrossRefGoogle Scholar
  40. 40.
    Jalan R, John TG, Redhead DN, et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995;90(11):1932–1937.PubMedGoogle Scholar
  41. 41.
    Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114(5):981–987.PubMedGoogle Scholar
  42. 42.
    Barange K, Peron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999;30(5):1139–1143.PubMedCrossRefGoogle Scholar
  43. 43.
    Laberge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993;187(2):413–420.PubMedGoogle Scholar
  44. 44.
    Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993;165(5):566–571.PubMedCrossRefGoogle Scholar
  45. 45.
    Haag K, Rossle M, Hauenstein KH, Sellingwer M, Ochs A, Blum U. Der transjugulare intrahepatische portosystemischhe Stent-Shunt (TTPS) in der Notfallbehandlung der portalen Hypertension. Intensivmed 1993;30:479–483.Google Scholar
  46. 46.
    Le Moine O, Deviere J, Ghysels M, Francois E, Rypens F, Van Gansbeke D. Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol 1994;207(Suppl):23–28.Google Scholar
  47. 47.
    Rubin RA, Haskal ZJ, O’Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995;90(4):556–563.PubMedGoogle Scholar
  48. 48.
    Jabbour N, Zajko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg 1996;2(2):139–147.PubMedCrossRefGoogle Scholar
  49. 49.
    Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996;111(1):138–146.PubMedCrossRefGoogle Scholar
  50. 50.
    Perarnau JM. Le shunt intra-hepatique (TIPS): 5 ans apres. Act Med Int Gastroenterol 1997;111:278–285.Google Scholar
  51. 51.
    Banares R, Casado M, Rodriguez-Laiz JM, et al. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998;93(l):75–79.PubMedGoogle Scholar
  52. 52.
    Gerbes AL, Gulberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TTPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Set 1998;43(11):2463–2469.CrossRefGoogle Scholar
  53. 53.
    Bizollon T, Dumortier J, Jouisse C, et al. Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol 2001;13(4):369–375.PubMedCrossRefGoogle Scholar
  54. 54.
    Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001;35(5):590–597.PubMedCrossRefGoogle Scholar
  55. 55.
    Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 1999;19(4):457–473.PubMedGoogle Scholar
  56. 56.
    Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM 1998;91(1):19–25.PubMedCrossRefGoogle Scholar
  57. 57.
    Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gaslroenterology 1999;117(3):626–631.CrossRefGoogle Scholar
  58. 58.
    Patch D, Armonis A, Sabin C, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999;44(2):264–269.PubMedCrossRefGoogle Scholar
  59. 59.
    Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36(4):494–500.PubMedCrossRefGoogle Scholar
  60. 60.
    Gulberg V, Schepke M, Geigenberger G, et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 2002;37(3):338–343.PubMedCrossRefGoogle Scholar
  61. 61.
    Pomier-Layrargues G, Villeneuve JP, Deschenes M, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48(3):390–396.PubMedCrossRefGoogle Scholar
  62. 62.
    Narahara Y, Kanazawa H, Kawamata H, et al. A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 2001;21(3):189–198.PubMedCrossRefGoogle Scholar
  63. 63.
    Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997;113(5):1623–1631.PubMedCrossRefGoogle Scholar
  64. 64.
    Garcia-Villarreal L, Martinez-Lagares F, Sierra A, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999;29(l):27–32.PubMedCrossRefGoogle Scholar
  65. 65.
    Merli M, Salerno F, Riggio O, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998;27(l):48–53.PubMedCrossRefGoogle Scholar
  66. 66.
    Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs. endoscopic banding in the prevention of variceal rebleeding: a long-term randomized trial. Gastroenterology 2000;118(4):6723.Google Scholar
  67. 67.
    Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126(11):858–865.PubMedGoogle Scholar
  68. 68.
    Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26(5):1115–1122.PubMedGoogle Scholar
  69. 69.
    Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349(9058):1043–1049.PubMedCrossRefGoogle Scholar
  70. 70.
    Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126(11):849–857.PubMedGoogle Scholar
  71. 71.
    Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110(3):832–839.PubMedCrossRefGoogle Scholar
  72. 72.
    GEAIH. Tips vs sclerotherapy plus propranolol in the prevention of variceal rebleeding—preliminary-results of a multicenter randomized trial. Hepatology 1995;22(4):761.Google Scholar
  73. 73.
    Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996;224(3):378–384.PubMedCrossRefGoogle Scholar
  74. 74.
    Jalan R, Bzeizi KI, Tripathi D, Lui HF, Redhead DN, Hayes PC. Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period. Eur J Gastroenterol Hepatol 2002;14(6):615–626.PubMedCrossRefGoogle Scholar
  75. 75.
    Escorsell A, Banares R, Garcia-Pagan JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35(2):385–392.PubMedCrossRefGoogle Scholar
  76. 76.
    Saner P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002;34(9):690–697.CrossRefGoogle Scholar
  77. 77.
    Khaitiyar JS, Luthra SK, Prasad N, Ratnakar N, Daruwala DK. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt—a comparative study. Hepatogastroenterology 2000;47(32):492–497.PubMedGoogle Scholar
  78. 78.
    Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16(6):1343–1349.PubMedCrossRefGoogle Scholar
  79. 79.
    Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol 1991;13(3):274–278.PubMedCrossRefGoogle Scholar
  80. 80.
    Ramond MJ, Valla D, Gotlib JP, Rueff B, Benhamou JP. Endoscopic obturation of esophagogastric varices with bucrylate. I. Clinical study of 49 patients. Gastroenterol Clin Biol 1986;10(8–9):575–579.PubMedGoogle Scholar
  81. 81.
    Lee GH, Kim JH, Lee KJ, et al. Life-threatening intraabdominal arterial embolization after histoacryl injection for bleeding gastric ulcer. Endoscopy 2000;32(5):422–424.PubMedCrossRefGoogle Scholar
  82. 82.
    See A, Florent C, Lamy P, Levy VG, Bouvry M. Cerebro vascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients. Gastroenterol Clin Biol 1986;10(8–9):604–607.PubMedGoogle Scholar
  83. 83.
    Przemioslo RT, McNair A, Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci 1999;44(4):778–781.PubMedCrossRefGoogle Scholar
  84. 84.
    Williams SG, Peters RA, Westaby D. Thrombin—an effective treatment for gastric variceal haemorrhage. Gut 1994;35(9):1287–1289.PubMedCrossRefGoogle Scholar
  85. 85.
    Yang WL, Tripathi D, Therapondos G, Todd A, Hayes PC. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 2002;97(6):1381–1385.PubMedCrossRefGoogle Scholar
  86. 86.
    Thomas PG, D’Cruz AJ. Distal splenorenal shunting for bleeding gastric varices. Br J Surg 1994;81(2):241–244.PubMedCrossRefGoogle Scholar
  87. 87.
    Stanley AJ, Jalan R, Ireland HM. Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997;11(1):171–176.PubMedCrossRefGoogle Scholar
  88. 88.
    Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheteriza-tion. Gastroenterology 1988;95(2):434–440.PubMedGoogle Scholar
  89. 89.
    Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 1986;6(4):318–331.PubMedCrossRefGoogle Scholar
  90. 90.
    Bellis L, Moitinho E, Abraldes JG, et al. Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shunt. Gut 2003;52(11:130–133.PubMedCrossRefGoogle Scholar
  91. 91.
    Brensing KA, Horsch M, Textor J, et al. Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt Scand J Gastroenterol 2002;37(9):1070–1076.Google Scholar
  92. 92.
    Luo B, Abrams G A, Fallon MB. Endothclin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998;29(4):571–578.PubMedCrossRefGoogle Scholar
  93. 93.
    Tripathi D, Lui HF, Helmy A, et al. Randomized controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut 2004;53:431–437.PubMedCrossRefGoogle Scholar
  94. 94.
    Otal P, Rousseau H, Vinel JP, Ducoin H, Hassissene S, Joffre F. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent. J Vase Interv Radiol 1999;10(2 Pt 1):183–188.Google Scholar
  95. 95.
    Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995;196(2):341–347.PubMedGoogle Scholar
  96. 96.
    Haskal ZJ, Davis A, McAllister A, Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology 1997;205(3):682–688.PubMedGoogle Scholar
  97. 97.
    Otal P, Smayra T, Bureau C, et al. Preliminary results of a new expanded-polytetrafluoroethylenecovered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 2002;178(l):141–147.PubMedGoogle Scholar
  98. 98.
    Rose JD, Pimpalwar S, Jackson RW. A new stent-graft for transjugular intrahepatic portosystemic shunts. Br J Radiol 2001;74(886):908–912.PubMedGoogle Scholar
  99. 99.
    Andrews RT, Saxon RR, Bloch RD, et al. Stent-grafts for de novo TIPS: technique and early results. J Vase Interv Radiol 1999;10(10):1371–1378.Google Scholar
  100. 100.
    Cejna M, Thurnher S, Pidlich J, Kaserer K, Schoder M, Lammer J. Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): a pilot study. Cardiovasc Intervent Radiol 1999;22(4):305–310.PubMedCrossRefGoogle Scholar
  101. 101.
    Haskal ZJ. Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts. Radiology 1999;213(3):759–766.PubMedGoogle Scholar
  102. 102.
    Saxon RR, Timmermans HA, Uchida BT, et al. Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study. J Vase Interv Radiol 1997;8(4):539–548.CrossRefGoogle Scholar
  103. 103.
    Cejna M, Peck-Radosavljevic M, Thurnher S, et al. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol2002;25(5):365–372.PubMedCrossRefGoogle Scholar
  104. 104.
    Otal P, Smayra T, Bureau C, et al. Preliminary results of a new expanded-polytetrafluoroelhylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 2002;178(l):141–147.PubMedGoogle Scholar
  105. 105.
    Bureau C, Pagan JCG, Layrargues GP, et al. The use of polytetrafluoroethylene (PTFE) covered stents improves the patency of tips: results of a randomized study. Hepatology 2002;36(4):525.Google Scholar
  106. 106.
    Bureau C, Otal P, Chabbert V, Peron JM, Rousseau H, Vinel JP. Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology 2002;36(6):1554.PubMedGoogle Scholar
  107. 107.
    Laberge JM, Kerlan RK. Liver infarction following TIPS with a PTFE-covered stent: is the covering the cause? Hepatology 2003;38(3):778–779.PubMedCrossRefGoogle Scholar
  108. 108.
    Haag K, Rossle M, Hauenstein KH, et al. Der transjugulare intrahepatische portosystemischhe Stent-Shunt (TIPS) in der Notfallbehandlung der portalen Hypertension. Intensivmed 1993;30:479–483.Google Scholar
  109. 109.
    Le Moine O, Deviere J, Ghysels M, Francois E, Rypens F, VanGansbeke D. Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol 1994;207(Suppl):23–28.Google Scholar
  110. 110.
    Rubin RA, Haskal ZJ, O’Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995;90(4):556–563.PubMedGoogle Scholar
  111. 111.
    Sauer P, Benz C, Theilmann L, Richter GM, Stremmel W, Stiehl A. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs. endoscopic banding in the prevention of variceal rebleeding: final results of a randomized study [Abstract]. Gastroenterology 1998;114:Al334.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Dhiraj Tripathi
    • 1
  • Peter C. Hayes
    • 1
  • Doris N. Redhead
    • 1
  • Rajiv Jalan
    • 2
  1. 1.Department of Hepatology and RadiologyRoyal InfirmaryEdinburgh
  2. 2.Institute of HepatologyRoyal Free and University College Medical SchoolLondonUK

Personalised recommendations